Molbio Diagnostics Ltd (MOLBIO) β Insider Trading | 1 October 2026 (2 announcements)
Molbio Diagnostics disclosed a shareholding update from India Business Excellence Fund III under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011, dated September 24, 2026, requesting BSE to take the disclosure on record.
About Molbio Diagnostics Ltd (MOLBIO)
Healthcare Β· Healthcare Β· Listed on BSE
π‘ Get AI alerts when MOLBIO files next
Free β’ Daily 5 PM digest β’ Track filings, board meetings, and corporate actions
Track MOLBIO β Freeπ‘ Ask AI about this filing
π More MOLBIO filings
- Announcement β 28 September 2026Molbio Diagnostics Ltd announced that its trading window will close on October 1, 2026, for insiders...
- π΄ Insider Trading β 25 September 2026India Business Excellence Fund III sold 30 lakh shares of Molbio Diagnostics on September 23, 2026, ...
- π‘ Board Meeting β 25 September 2026Molbio Diagnostics announced the re-appointment of K.S. Kamalakara & Co as cost auditor for FY 2026-...
- π΄ Insider Trading β 25 September 2026Molbio Diagnostics disclosed a shareholding update from India Business Excellence Fund III under SEB...
- π΄ Announcement β 17 September 2026Molbio Diagnostics announced a virtual investor meeting on September 22, 2026 at 11:00 AM IST to dis...
π₯ Also filed on 1 October 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only β not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
π‘ Get AI alerts when MOLBIO files new disclosures
Track MOLBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track MOLBIO β FreeFree account Β· 2 AI queries/day